Section Arrow
DVA.NYSE
- DaVita
Quotes are at least 15-min delayed:2025/08/25 11:15 EDT
Regular Hours
Last
 138.83
-1.53 (-1.09%)
Day High 
141 
Prev. Close
140.36 
1-M High
151.85 
Volume 
91.36K 
Bid
138.68
Ask
138.89
Day Low
138.65 
Open
140.075 
1-M Low
126.07 
Market Cap 
10.04B 
Currency USD 
P/E 13.83 
%Yield -- 
10-SMA 135.09 
20-SMA 136.53 
50-SMA 139.52 
52-W High 179.6 
52-W Low 126.07 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
10.15/12.66
Enterprise Value
21.42B
Balance Sheet
Book Value Per Share
-5.17
Cash Flow
Cash Flow Yield
0.16
Income Statement
Total Revenue
498.00M
Operating Revenue Per Share
166.59
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MODVModivCare0.7255-0.3445-32.20%-- 
AGLagilon health1.385+0.055+4.14%-- 
CMPSCOMPASS Pathways Plc4.82+0.21+4.56%-- 
TOIOncology Institute (The)3.6157-0.1743-4.60%-- 
AVAHAveanna Healthcare Holdings7.54+0.07+0.94%83PE
Quotes are at least 15-min delayed:2025/08/25 11:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.